Recruiting

KF-STRIDE 3.0

Sponsor:

Kessler Foundation

Code:

NCT07168941

Conditions

Autism Spectrum Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

KF-STRIDE

Study Details

Brief summary:

Examine the acceptability, usability, feasibility, and initial efficacy of KF-STRIDE 3.0, the data from which will serve as a basis for a future fully powered RCT

Conditions

Autism Spectrum Disorder

Study ID

NCT07168941

Start date

Jan 26, 2026

Status verified date

Aug, 2026

Completion date

Jul 1, 2027

Anticipated

Primary completion date

Jan 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Participants live in the United States of America
  • Participants speak English Fluently and at a 4th grade reading level

Exclusion Criteria:

  • Participants have a history of significant psychiatric illness (like bipolar disorder, schizophrenia, or psychosis)
  • Participants have a history of substance abuse

Study Design

Enrollment

30 participants

Anticipated

Allocation

Randomized

Intervention Model

Parallel Assignment

Primary purpose

Treatment

Interventions and Outcome Measures

Arms

experimental: Kessler Foundation STRength IDentification and Expression (KF-STRIDE)

no intervention: Services as Usual

Interventions

KF-STRIDE

KF Stride works to improve identification (awareness) of personal character strengths and 2) express them in a socially appropriate way during a job interview

Primary outcome measure

  • 20-minute long video-recorded Mock Job Interview, Autism Mock Interview Rating-Scale(A-MIRS) [ Time Frame: Baseline, Immediate Post-Test between weeks 7 and 8 ]
  • Work Readiness Scale [ Time Frame: Baseline, Immediate Post-Test between weeks 7 and 8 ]
  • Employment Status [ Time Frame: Baseline, Immediate Post-Test between weeks 7 and 8 ]

Central Contacts and Locations

Locations

Kessler Foundation

Recruiting

East Hanover, New Jersey, United States, 07420

Contacts

More Information

Sponsor

Kessler Foundation

Last update posted

Aug 28, 2026

Last verified

Aug, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Kessler Foundation on 2026-08-28.